AGL 40.10 Increased By ▲ 0.10 (0.25%)
AIRLINK 131.00 Increased By ▲ 1.47 (1.13%)
BOP 6.81 Increased By ▲ 0.13 (1.95%)
CNERGY 4.61 Decreased By ▼ -0.02 (-0.43%)
DCL 9.04 Increased By ▲ 0.10 (1.12%)
DFML 43.80 Increased By ▲ 2.11 (5.06%)
DGKC 84.25 Increased By ▲ 0.48 (0.57%)
FCCL 33.10 Increased By ▲ 0.33 (1.01%)
FFBL 79.25 Increased By ▲ 3.78 (5.01%)
FFL 11.70 Increased By ▲ 0.23 (2.01%)
HUBC 110.75 Increased By ▲ 0.20 (0.18%)
HUMNL 14.72 Increased By ▲ 0.16 (1.1%)
KEL 5.33 Decreased By ▼ -0.06 (-1.11%)
KOSM 8.30 Decreased By ▼ -0.10 (-1.19%)
MLCF 39.85 Increased By ▲ 0.06 (0.15%)
NBP 61.00 Increased By ▲ 0.71 (1.18%)
OGDC 201.70 Increased By ▲ 2.04 (1.02%)
PAEL 26.82 Increased By ▲ 0.17 (0.64%)
PIBTL 7.87 Increased By ▲ 0.21 (2.74%)
PPL 161.60 Increased By ▲ 3.68 (2.33%)
PRL 26.75 Increased By ▲ 0.02 (0.07%)
PTC 18.58 Increased By ▲ 0.12 (0.65%)
SEARL 82.18 Decreased By ▼ -0.26 (-0.32%)
TELE 8.27 Decreased By ▼ -0.04 (-0.48%)
TOMCL 34.59 Increased By ▲ 0.08 (0.23%)
TPLP 9.15 Increased By ▲ 0.09 (0.99%)
TREET 17.19 Decreased By ▼ -0.28 (-1.6%)
TRG 61.00 Decreased By ▼ -0.32 (-0.52%)
UNITY 27.50 Increased By ▲ 0.07 (0.26%)
WTL 1.44 Increased By ▲ 0.06 (4.35%)
BR100 10,557 Increased By 150 (1.44%)
BR30 32,067 Increased By 353.6 (1.11%)
KSE100 98,576 Increased By 1247.1 (1.28%)
KSE30 30,675 Increased By 482.5 (1.6%)

More than 130 therapies are being investigated as possible treatments for the coronavirus, a leading pharmaceutical industry association said Thursday.

Unprecedented efforts to collaborate across the pharmaceutical industry have significantly accelerated the search for safe and effective treatments for the novel coronavirus, the International Federation of Pharmaceutical Manufacturers and Associations said.

"Over 130 COVID-19 therapeutics are under investigation," IFPMA director Thomas Cueni told a virtual briefing, along with a number of pharmaceutical company executives.

The team detailed work on different therapies currently being considered, including anti-malarials, anti-virals, immunotherapies and plasma treatments. Cueni said 77 of them were existing drugs being tested to see if they could be repurposed for use against COVID-19, while 68 were new treatments.

Most were still in the early stages of testing, he said, adding that more than 25 clinical trials had already begun.

"This is really good news for all of us, because we do hope that sooner rather than later we will see first successes in containing and treating COVID-19," he said.

Copyright Agence France-Presse, 2020

Comments

Comments are closed.